An international pharmaceutical company growing rapidly through multiple simultaneous acquisitions was severely challenged to integrate a variety of diverse pharmacovigilance (PV) operating processes into one harmonised system.

Recent Health Authority inspections and internal audits highlighted a number of compliance issues related to process inconsistencies and regulatory shortcomings.

To help address these issues, Navitas was engaged to develop and implement a new integrated operating model.

© 2019 Navitas Life Sciences | Privacy Policy